Skip to content
Application 103964
- Type
- BLA
- Sponsor
- HOFFMAN-LA ROCHE
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | PEGASYS | PEGINTERFERON ALFA-2A | VIAL; SUBCUTANEOUS | 180UG/VIAL | No | No |
| 002 | PEGASYS | PEGINTERFERON ALFA-2A | SYRINGE | 180U/5ML | No | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 0004-0350 | Pegasys | peginterferon alfa-2a | Genentech, Inc. | BLA | Current |
| 0004-0350 | Pegasys | peginterferon alfa-2a | Genentech, Inc. | BLA | Current |
| 0004-0350 | Pegasys | peginterferon alfa-2a | Genentech, Inc. | BLA | Current |
| 0004-0350 | Pegasys | peginterferon alfa-2a | Genentech, Inc. | BLA | Current |
| 0004-0350 | Pegasys | peginterferon alfa-2a | Genentech, Inc. | BLA | Current |
| 0004-0350 | Pegasys | peginterferon alfa-2a | Genentech, Inc. | BLA | Current |
| 0004-0357 | Pegasys | peginterferon alfa-2a | Genentech, Inc. | BLA | Current |
| 0004-0357 | Pegasys | peginterferon alfa-2a | Genentech, Inc. | BLA | Current |
| 0004-0357 | Pegasys | peginterferon alfa-2a | Genentech, Inc. | BLA | Current |
| 0004-0357 | Pegasys | peginterferon alfa-2a | Genentech, Inc. | BLA | Current |
| 0004-0357 | Pegasys | peginterferon alfa-2a | Genentech, Inc. | BLA | Current |
| 0004-0357 | Pegasys | peginterferon alfa-2a | Genentech, Inc. | BLA | Current |
| 0004-0365 | Pegasys | peginterferon alfa-2a | Genentech, Inc. | BLA | Current |
| 0004-0365 | Pegasys | peginterferon alfa-2a | Genentech, Inc. | BLA | Current |
| 82154-0449 | Pegasys | peginterferon alfa-2a | zr pharma& GmbH | BLA | Current |
| 82154-0451 | Pegasys | peginterferon alfa-2a | zr pharma& GmbH | BLA | Current |